Bio-Rad Laboratories, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Bio-Rad Laboratories, Inc. on April 28, 2015. The filing details the outcomes of shareholder votes regarding director elections and the ratification of independent auditors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters.
Material Changes
No material financial changes are reported in this filing. The document confirms the successful election of all nominated directors and the ratification of KPMG LLP as the independent auditor for the fiscal year ending December 31, 2015.
Outlook and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies.
Key Facts for Investors
- All nominated directors for Class A and Class B Common Stock were elected with majority affirmative votes.
- Shareholders ratified the appointment of KPMG LLP as the independent auditor for the 2015 fiscal year.
- Broker non-votes were recorded for director elections but did not affect the outcome as a majority of votes cast was required.
- The report was signed by Christine A. Tsingos, Executive Vice President and Chief Financial Officer, on May 4, 2015.